SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001214659-16-015438
Filing Date
2016-12-23
Accepted
2016-12-23 16:15:41
Documents
7
Period of Report
2016-12-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 d12221608k.htm 8-K 35617
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 434217
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 28597
4 EXHIBIT 10.3 ex10_3.htm EX-10.3 19708
5 EXHIBIT 10.4 ex10_4.htm EX-10.4 19764
6 EXHIBIT 10.5 ex10_5.htm EX-10.5 19245
7 EXHIBIT 10.6 ex10_6.htm EX-10.6 19261
  Complete submission text file 0001214659-16-015438.txt   577693
Mailing Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878
Business Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35798 | Film No.: 162069136
SIC: 2834 Pharmaceutical Preparations